Immunoassays and diagnostic antibodies for Perkinsus spp. pathogens of marine molluscs.

Autor: Hanrio E; The University of Western Australia, Crawley 6009, Western Australia, Australia., Batley J, Dungan CF, Dang C
Jazyk: angličtina
Zdroj: Diseases of aquatic organisms [Dis Aquat Organ] 2021 Nov 04; Vol. 147, pp. 13-23. Date of Electronic Publication: 2021 Nov 04.
DOI: 10.3354/dao03635
Abstrakt: Perkinsus sp. protozoans are parasites of a wide variety of molluscs around the world and are responsible for episodes of mass mortalities and large economic losses for aquaculture industries and fisheries. The first step towards the management of infectious episodes is the reliable detection of Perkinsus species. While historic methods for diagnosis of Perkinsus sp. infections in mollusc hosts include histological, in vitro, molecular-genetic, and immunoassays, antibody-based diagnostic assays may prove most practical with development of improved reagents and techniques. This paper reviews historic developments of antibodies against Perkinsus species, and of diagnostic immunoassays. Thirteen research papers reported the development of antibodies against Perkinsus sp. or their extracellular products, mainly P. olseni and P. marinus. Nine of those tested the cross-reactivity of their antibodies against different life stages or species than the one used as immunogen. While all antibodies raised against trophozoites labelled hypnospores, several antibodies raised against hypnospores did not label trophozoites, suggesting antigenic differences between those cell types. Antibody specificity studies showed that there is antigenic heterogeneity between Perkinsus species and Perkinsus-like organisms, and also that common epitopes occur among Perkinsus species, as well as some dinoflagellates. This review summarizes the current knowledge and aims at helping the future development of Perkinsus species-specific antibodies and immunoassays.
Databáze: MEDLINE